Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cilazapril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE known ✓ | P12821 | 13/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MME | P08473 | 2/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.55 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.55 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cilazapril SCHEMBL14287315 | 1.00 | ACE (0.76) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL24962 | 1.00 | ACE (0.76) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL16290008 | 1.00 | ACE (0.76) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL29394939 | 1.00 | ACE (0.76) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL10562310 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL19469323 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL15263655 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL136488 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL24961 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 | |
| Cilazapril SCHEMBL6508385 | 0.99 | ACE (0.75) | ACELMNAMMEABCB11AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0094095-B1 | BICYCLIC CARBOXYLIC ACIDS AND THEIR ALKYL AND ARALKYL ESTERS | F. HOFFMANN-LA ROCHE AG (CH) | 1990-09-19 | — | — | EP | claimed |
| US-4512924-A | HYPOTENSIVE AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1985-04-23 | — | — | US | claimed |
| US-4808713-A | Anthypertensive pyridazo [1,2-a][1,2]diazepines | HOFFMAN-LA ROCHE INC. (US) | 1989-02-28 | — | — | US | disclosed |
| US-4772701-A | Pyridazo[1,2]pyridazines and pyrazolo[1,2]pyridazines as antihypertensives | HOFFMANN-LA ROCHE INC. (US) | 1988-09-20 | — | — | US | disclosed |
| US-4658024-A | Pyrazolo [1,2-a][1,2]-diazepines useful as antihypertensives | HOFFMANN-LA ROCHE INC. (US) | 1987-04-14 | — | — | US | disclosed |
| US-4512924-A | HYPOTENSIVE AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1985-04-23 | — | — | US | disclosed |